アミノグリコシドの世界市場レポート 2025年

アミノグリコシドの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.3％で24億6,000万米ドルに成長します。予測期間の成長は、抗生物質スチュワードシップの進歩、個別化医療へのアプローチ、ドラッグデリバリーの革新、抗生物質耐性株の世界的拡大、希少疾患への注目の高まり、皮膚科での用途拡大、抗生物質使用に関する患者教育などに起因すると考えられます。予測期間における主な動向としては、バイオテクノロジーの革新、併用療法、生産技術の進歩、価格競争などが挙げられます。

アミノグリコシド市場は、動物疾病アウトブレイクの増加により成長が見込まれます。このようなアウトブレイクは動物の正常な機能に大きな影響を与え、動物医療で広く使用されているアミカシンやゲンタマイシンのようなアミノグリコシドの需要を生み出しています。最近の例では、2022年7月にカナダのウッド・バッファロー国立公園の遠隔地で炭疽菌の発生が報告され、監視されています。この動向は今後も続くと予想され、市場内のアミノグリコシドの需要をさらに押し上げると思われます。

ペット飼育の増加はアミノグリコシド市場の拡大に拍車をかける。伴侶として飼われる動物の世話や健康に責任を持つペット所有者の増加は、顧客基盤を拡大することで市場の成長に寄与しています。このようなペット飼育の急増は、ペットの予防ヘルスケアの実践を促し、様々な健康ニーズに対応するためにアミノグリコシドを含む動物用医薬品への投資を促進します。2023年3月にImprove Internationalが発表したところによると、英国では約57％の世帯、合計1,620万世帯が3,800万匹のペットを飼っています。このようなペット飼育の増加は、依然としてアミノグリコシド市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のアミノグリコシド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアミノグリコシド市場：成長率分析
• 世界のアミノグリコシド市場の実績：規模と成長, 2019-2024
• 世界のアミノグリコシド市場の予測：規模と成長, 2024-2029, 2034F
• 世界のアミノグリコシド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアミノグリコシド市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ネオマイシン
• トブラマイシン
• ゲンタマイシン
• アミカシン
• パロモマイシン
• ストレプトマイシン
• カナマイシン
• その他の製品
• 世界のアミノグリコシド市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注入（非経口）
• フィード
• 乳房内
• 外用
• 経口
• 世界のアミノグリコシド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 獣医
• 皮膚感染症
• 呼吸器疾患
• 尿路感染症と骨盤疾患
• その他の疾患
• 世界のアミノグリコシド市場：ネオマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所用製剤
• 経口製剤
• 世界のアミノグリコシド市場：トブラマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸入ソリューション
• 注入
• 眼科用ソリューション
• 世界のアミノグリコシド市場：ゲンタマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注入
• 外用製剤
• 眼科用ソリューション
• 世界のアミノグリコシド市場：アミカシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注入
• 吸入ソリューション
• 世界のアミノグリコシド市場：パロモマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口製剤
• 注入
• 世界のアミノグリコシド市場：ストレプトマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注入
• 併用療法
• 世界のアミノグリコシド市場：カナマイシンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注入
• 経口製剤
• 世界のアミノグリコシド市場：その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミノグリコシド併用
• 新規アミノグリコシド誘導体

第7章 地域別・国別分析

• 世界のアミノグリコシド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアミノグリコシド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アミノグリコシド市場：競合情勢
• アミノグリコシド市場：企業プロファイル
  • Kremoint Pharma Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Vega Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Jiangxi Bolai Pharmacy Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Xian Wison Biological Technology Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Hangzhou Uniwise International Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• HuvePharma Inc.
• Yi Chang Veterinary Medicine Factory
• Medson Pharmaceuticals
• Medico Remedies Pvt. Ltd.
• Cipla Limited
• Pfizer Inc.
• Allergan PLC
• Teva Pharmaceutical Industries Ltd.
• Zoetis Inc.
• Novartis AG
• Johnson & Johnson Inc.
• Bristol Myers Squibb Company
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Zydus Lifescience limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アミノグリコシド市場2029：新たな機会を提供する国
• アミノグリコシド市場2029：新たな機会を提供するセグメント
• アミノグリコシド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Aminoglycosides, a class of antibiotics renowned for their ability to impede protein synthesis, play a crucial role in treating infections caused by aerobic gram-negative bacilli. These infections commonly manifest in the abdomen and urinary tract, as well as in cases of bacteremia and endocarditis.

Among the primary products in the aminoglycoside category are neomycin, tobramycin, gentamicin, amikacin, paromomycin, streptomycin, kanamycin, and others. Neomycin, for instance, is specifically employed to prevent bacterial infections in the intestines. Derived from the metabolic products of Streptomyces fradiae, neomycin is recognized as a broad-spectrum aminoglycoside antibiotic. Aminoglycosides are administered through various routes, including injectables (parenteral), feed, intra-mammary, topical, and oral applications. Their use extends across veterinary medicine, addressing conditions such as skin infections, respiratory diseases, urinary tract infections, pelvic diseases, and various other ailments.

The aminoglycosides market research report is one of a series of new reports from The Business Research Company that provides aminoglycosides market statistics, including aminoglycosides industry global market size, regional shares, competitors with an aminoglycosides market share, detailed aminoglycosides market segments, market trends and opportunities, and any further data you may need to thrive in the aminoglycosides industry. This aminoglycosides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aminoglycosides market size has grown steadily in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments.

The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition.

The aminoglycosides market is anticipated to witness growth due to the escalating incidences of animal disease outbreaks. These outbreaks significantly impact the normal functions of animals and create a demand for aminoglycosides, like amikacin and gentamicin, widely used in veterinary medicine. A recent example is the anthrax outbreak reported and monitored in remote areas of Canada's Wood Buffalo National Park in July 2022. This trend is expected to continue, further boosting the demand for aminoglycosides within the market.

The growing ownership of pets is poised to fuel the expansion of the aminoglycosides market. The increased number of pet owners, who are responsible for the care and well-being of animals kept as companions, contributes to the market's growth by expanding the customer base. This surge in pet ownership encourages preventive healthcare practices for pets and drives investments in veterinary pharmaceuticals, including aminoglycosides, to address various health needs. An example of this growth is evident in the UK, where approximately 57% of households, totaling 16.2 million, have 38 million pets, as reported by Improve International in March 2023. This rise in pet ownership remains a driving force behind the growth of the aminoglycosides market.

Process innovation is a significant trend in the aminoglycosides market, with major companies focusing on new process solutions to enhance their competitive position. For example, in February 2024, Cipla Limited, an India-based pharmaceutical company, received approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic. This antibiotic is specifically indicated for treating complicated urinary tract infections (cUTIs), including pyelonephritis.

Major companies in the aminoglycosides market are concentrating on developing innovative products, including active ingredients that are effective against specific bacterial pathogens. An active ingredient is the chemical component within a product, such as a drug or pesticide, that produces the desired therapeutic or biological effect. For example, in July 2023, Bimeda US, a U.S.-based animal health company, launched SpectoGard, an injectable solution designed to treat various bacterial infections in cattle. This product contains spectinomycin sulfate, an antibiotic used for treating bovine respiratory disease (BRD) caused by particular bacterial pathogens. The solution offers veterinarians and cattle producers in the U.S. a convenient treatment option to enhance herd health. Its FDA status underscores its safety and efficacy for livestock use.

In April 2022, Animal Dermatology Group Inc., a US-based veterinary company, executed the acquisition of Austin Veterinary Dermatology & Allergy. The strategic acquisition, completed for an undisclosed amount, is part of Animal Dermatology Group's ongoing efforts to expand its geographic presence and consolidate its market position. Through this acquisition, the company aims to broaden its scope and offer top-tier treatment for skin diseases across more regions. This move reinforces Animal Dermatology Group's commitment to enhancing its expertise in veterinary dermatology. Austin Veterinary Dermatology & Allergy, a US-based biotechnology company, aligns well with the expansion goals of Animal Dermatology Group.

Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc

Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aminoglycosides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aminoglycosides market consists of sales of plazomicin and netilmicin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aminoglycosides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aminoglycosides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aminoglycosides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aminoglycosides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Neomycin; Tobramycin; Gentamicin; Amikacin; Paromomycin; Streptomycin; Kanamycin; Other Products
• 2) By Route Of Administration: Injectables (Parenteral); Feed; Intra-Mammary; Topical; Oral
• 3) By Application: Veterinary; Skin Infection; Respiratory Diseases; UTI And Pelvic Diseases; Other Diseases
• Subsegments:
• 1) By Neomycin: Topical Formulations; Oral Formulations
• 2) By Tobramycin: Inhalation Solutions; Injectable Formulations; Ophthalmic Solutions
• 3) By Gentamicin: Injectable Formulations; Topical Formulations; Ophthalmic Solutions
• 4) By Amikacin: Injectable Formulations; Inhalation Solutions
• 5) By Paromomycin: Oral Formulations; Injectable Formulations
• 6) By Streptomycin: Injectable Formulations; Combination Therapies
• 7) By Kanamycin: Injectable Formulations; Oral Formulations
• 8) By Other Products: Combinations Of Aminoglycosides; Novel Aminoglycoside Derivatives
• Companies Mentioned: Kremoint Pharma Pvt. Ltd.; Vega Pharma Ltd.; Jiangxi Bolai Pharmacy Co. Ltd.; Xian Wison Biological Technology Co. Ltd.; Hangzhou Uniwise International Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aminoglycosides Market Characteristics

3. Aminoglycosides Market Trends And Strategies

4. Aminoglycosides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aminoglycosides Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aminoglycosides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aminoglycosides Market Growth Rate Analysis
• 5.4. Global Aminoglycosides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aminoglycosides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aminoglycosides Total Addressable Market (TAM)

6. Aminoglycosides Market Segmentation

• 6.1. Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neomycin
• Tobramycin
• Gentamicin
• Amikacin
• Paromomycin
• Streptomycin
• Kanamycin
• Other Products
• 6.2. Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectables (Parenteral)
• Feed
• Intra-Mammary
• Topical
• Oral
• 6.3. Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary
• Skin Infection
• Respiratory Diseases
• UTI And Pelvic Diseases
• Other Diseases
• 6.4. Global Aminoglycosides Market, Sub-Segmentation Of Neomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Formulations
• Oral Formulations
• 6.5. Global Aminoglycosides Market, Sub-Segmentation Of Tobramycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhalation Solutions
• Injectable Formulations
• Ophthalmic Solutions
• 6.6. Global Aminoglycosides Market, Sub-Segmentation Of Gentamicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Topical Formulations
• Ophthalmic Solutions
• 6.7. Global Aminoglycosides Market, Sub-Segmentation Of Amikacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Inhalation Solutions
• 6.8. Global Aminoglycosides Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Formulations
• Injectable Formulations
• 6.9. Global Aminoglycosides Market, Sub-Segmentation Of Streptomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Combination Therapies
• 6.10. Global Aminoglycosides Market, Sub-Segmentation Of Kanamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Oral Formulations
• 6.11. Global Aminoglycosides Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combinations Of Aminoglycosides
• Novel Aminoglycoside Derivatives

7. Aminoglycosides Market Regional And Country Analysis

• 7.1. Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aminoglycosides Market

• 8.1. Asia-Pacific Aminoglycosides Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aminoglycosides Market

• 9.1. China Aminoglycosides Market Overview
• 9.2. China Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aminoglycosides Market

• 10.1. India Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aminoglycosides Market

• 11.1. Japan Aminoglycosides Market Overview
• 11.2. Japan Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aminoglycosides Market

• 12.1. Australia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aminoglycosides Market

• 13.1. Indonesia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aminoglycosides Market

• 14.1. South Korea Aminoglycosides Market Overview
• 14.2. South Korea Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aminoglycosides Market

• 15.1. Western Europe Aminoglycosides Market Overview
• 15.2. Western Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aminoglycosides Market

• 16.1. UK Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aminoglycosides Market

• 17.1. Germany Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aminoglycosides Market

• 18.1. France Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aminoglycosides Market

• 19.1. Italy Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aminoglycosides Market

• 20.1. Spain Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aminoglycosides Market

• 21.1. Eastern Europe Aminoglycosides Market Overview
• 21.2. Eastern Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aminoglycosides Market

• 22.1. Russia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aminoglycosides Market

• 23.1. North America Aminoglycosides Market Overview
• 23.2. North America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aminoglycosides Market

• 24.1. USA Aminoglycosides Market Overview
• 24.2. USA Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aminoglycosides Market

• 25.1. Canada Aminoglycosides Market Overview
• 25.2. Canada Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aminoglycosides Market

• 26.1. South America Aminoglycosides Market Overview
• 26.2. South America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aminoglycosides Market

• 27.1. Brazil Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aminoglycosides Market

• 28.1. Middle East Aminoglycosides Market Overview
• 28.2. Middle East Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aminoglycosides Market

• 29.1. Africa Aminoglycosides Market Overview
• 29.2. Africa Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aminoglycosides Market Competitive Landscape And Company Profiles

• 30.1. Aminoglycosides Market Competitive Landscape
• 30.2. Aminoglycosides Market Company Profiles
  • 30.2.1. Kremoint Pharma Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Vega Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Jiangxi Bolai Pharmacy Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Xian Wison Biological Technology Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hangzhou Uniwise International Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Aminoglycosides Market Other Major And Innovative Companies

• 31.1. HuvePharma Inc.
• 31.2. Yi Chang Veterinary Medicine Factory
• 31.3. Medson Pharmaceuticals
• 31.4. Medico Remedies Pvt. Ltd.
• 31.5. Cipla Limited
• 31.6. Pfizer Inc.
• 31.7. Allergan PLC
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Zoetis Inc.
• 31.10. Novartis AG
• 31.11. Johnson & Johnson Inc.
• 31.12. Bristol Myers Squibb Company
• 31.13. Sandoz International GmbH
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. Zydus Lifescience limited

32. Global Aminoglycosides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aminoglycosides Market

34. Recent Developments In The Aminoglycosides Market

35. Aminoglycosides Market High Potential Countries, Segments and Strategies

• 35.1 Aminoglycosides Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aminoglycosides Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aminoglycosides Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer